Home
Ultra-Committed
- - - To transform the lives of as many people living with rare diseases as possible, we dedicate ourselves every day to the development and delivery of treatments of rare diseases where none currently exist.
  - - Ultra-Committed
      
      Learn more
Research
- - - We develop therapies for rare and ultrarare genetic diseases by exploring an array of drug modalities to select the best treatment strategy for each genetic disease we are studying.
  - - Research
      
      Learn more
Medicines
Partnerships
Join Our Team
- - - We have built a talented team and a vibrant, people-first culture. We share a passion for helping those living with rare diseases.
  - - Join our team
      
      Learn more
Newsroom
- - - Access news releases, presentations, and blog posts to follow the latest developments at Ultragenyx.
  - - Newsroom
      
      Learn more
Investors

Leadership

Led by an experienced team

Management team

We have built a management team with experience in all aspects of biopharmaceutical development and commercialization to drive the company forward.

Emil D Kakkis

Emil D. Kakkis, M.D., Ph.D. >
Founder, President and Chief Executive Officer, Ultragenyx

Howard Horn

Howard Horn >
Chief Financial Officer and Executive Vice President, Corporate Strategy

Eric Crombez

Eric Crombez, M.D. >
Chief Medical Officer and Executive Vice President

Erik Harris

Erik Harris >
Chief Commercial Officer and Executive Vice President

Dennis Huang

Dennis Huang >
Chief Technical Operations Officer and Executive Vice President, Gene Therapy Research and Development

Thomas Kassberg

Thomas Kassberg >
Chief Business Officer and Executive Vice President

Ernie Meyer

Ernie Meyer >
Chief Human Resources Officer and Executive Vice President

Karah Parschauer

Karah Parschauer >
Chief Legal Officer and Corporate Affairs, EVP

John Pinion

John Pinion >
Chief Quality Operations Officer and Executive Vice President, Translational Sciences

Board of directors

Our Board provides us with strategic guidance as we advance our mission of making a meaningful difference in the lives of patients with rare genetic diseases.

Emil D Kakkis

Emil D. Kakkis, M.D., Ph.D. >
Founder, President and Chief Executive Officer, Ultragenyx

Daniel G

Daniel G. Welch >
Chairperson
Biotechnology Executive

Deborah Dunsire

Deborah Dunsire, M.D. >
Physician and Biotechnology Executive

Matthew K Fust

Matthew K. Fust >
Biotechnology Executive

Michael Narachi

Michael Narachi >
Biotechnology Executive

Amrit Ray

Amrit Ray, M.D., M.B.A. >
Biopharmaceuticals Research and Development Executive

Corsee Sanders

Corsee Sanders, Ph.D. >
Biotechnology Executive

Shehnaaz Suliman

Shehnaaz Suliman, M.D. (MB ChB), M.B.A., M.Phil. >
Biotechnology Executive

Discover more about Ultragenyx:

Partnerships Card

Partnerships

Learn about partnership opportunities with Ultragenyx.

Partner with us

Ultra Committed Card

We are Ultra-Committed

Our mission is to transform as many lives of people living with rare diseases as possible.

Learn about our passion